Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses... Show more
Primis Financial Corp. (FRST) is a McLean, Virginia-based bank holding company for Primis Bank. While it retains a traditional community and commercial banking core, its competitive differentiation increasingly lies in two national specialty franchises. The mortgage warehouse segment provides short-term lines of credit to residential mortgage originators across much of the United States, while the Panacea Financial platform serves medical, dental, and veterinary professionals with niche lending and banking products.
This structure gives Primis exposure to higher-yielding, fee-generating businesses that are less dependent on a single geographic footprint. Analysts at Raymond James have characterized the company as a "unique" Virginia franchise combining a community bank core with national mortgage warehouse and healthcare platforms. The strategic rationale is straightforward: specialty niches typically command better pricing and more durable customer relationships than commodity lending, which supports a more resilient medium-term NIM.
The company's book value and profitability metrics remain modest relative to larger peers, and its smaller scale (market capitalization near $380 million) is a structural consideration. However, an efficiency ratio that management and sell-side analysts describe as favorable suggests the cost base is already lean, positioning the bank to translate revenue growth into earnings as the business scales.
Several near-term developments could shape investor sentiment. The next confirmed earnings release is scheduled for late October 2026, a natural checkpoint for validating loan growth, NIM trajectory, and credit quality after a second quarter in which net interest income rose roughly 34% year over year and NIM expanded meaningfully.
The ongoing digital core conversion is a discrete, measurable catalyst. Management has guided to approximately $6.1 million of annual earnings improvement once the migration is complete, providing a visible tailwind that does not depend on favorable rate or credit conditions.
Analyst activity has been notably constructive. Coverage was initiated in 2026 by Raymond James with a Strong Buy rating and by Keefe, Bruyette & Woods (KBW) with an Outperform rating, with both firms framing Primis as being at a profitability "inflection point." According to S&P Global data, the consensus among four covering analysts is a "Strong Buy," with an average one-year price target near $18.94 and a range spanning roughly $18 to $20. That said, sentiment is not uniformly upward: Raymond James lowered its target from $19 to $18 in early October 2026 while maintaining its Strong Buy rating, citing expectations for solid fundamentals including healthy commercial activity, back-book repricing, diversified fee income, and robust capital. This mixed-but-positive picture reflects growing confidence tempered by execution-timing caution.
Capital allocation is another watch item. A dividend yield near 2.6% and a recent share repurchase program signal a commitment to returning capital, while strong capital levels provide flexibility for balance-sheet remixing and selective growth.
As a regional bank with substantial mortgage exposure, Primis is highly sensitive to the interest-rate environment and the housing market. Falling or stabilizing benchmark rates can compress NIM on floating-rate assets but also tend to stimulate mortgage refinancing and origination activity, directly benefiting the warehouse lending and mortgage segments. Conversely, persistently high rates would support lending yields but weigh on origination volumes.
Credit is the other macro lever. Primis reported a specific reserve tied to a single non-accrual loan in the second quarter, underscoring that concentrated commercial real estate (CRE) exposure remains a risk in a sector still adjusting to post-pandemic office and property valuations. Positively, non-performing assets fell sharply, and the allowance coverage ratio improved, suggesting broader asset quality trends are firming.
On the funding side, a rise in Federal Home Loan Bank (FHLB) advances indicates greater reliance on wholesale funding, which is typically more rate-sensitive and less "sticky" than core deposits. How Primis manages its deposit franchise and funding mix will be central to margin sustainability. Finally, regulatory climate and merger-and-acquisition (M&A) activity among regional banks could reshape competitive dynamics, though Primis's national niche platforms provide some insulation from purely local competition.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool designed to help traders assess whether a stock, ETF, or other asset may trend bullish, bearish, or sideways over the next week or month. It is built to support users in spotting developing trends, evaluating possible breakouts or reversals, and exploring predictions across a broad universe of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality, making it a practical companion to fundamental research for those monitoring names like FRST. Explore the platform to see how its predictive signals may complement your own market positioning analysis.
Looking toward 2026 and beyond, Primis Financial's trajectory hinges on executing its profitability inflection. Consensus estimates compiled from S&P Global data project a sharp rebound in earnings per share (EPS) to roughly $1.38 in fiscal 2026, up from a depressed base, followed by further growth to near $1.93 in 2027. Revenue is likewise expected to expand from about $111 million in 2025 toward roughly $137 million in 2026 and $149 million in 2027.
The most important long-term themes are margin sustainability, specialty-platform scaling, and cost discipline. If the digital core conversion delivers its guided savings and the mortgage warehouse and healthcare platforms continue growing fee income, Primis could sustain improving returns on equity (ROE, a measure of profitability relative to shareholder capital), which currently sits near 13%. Competitive threats include larger national lenders encroaching on niche segments and the inherent cyclicality of mortgage demand.
Capital allocation will also matter. A steady dividend and opportunistic buybacks can support per-share value, while disciplined loan growth funded by a stable deposit base would strengthen the funding profile. Ultimately, whether analyst price targets and the "inflection point" narrative are validated will depend less on headline rates than on Primis's ability to compound earnings through its specialized platforms and operating leverage.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MUZ | 11.64 | 0.31 | +2.74% |
| Defiance Daily Target 2X Short MU ETF | |||
| EZM | 75.71 | -0.07 | -0.09% |
| WisdomTree U.S. MidCap Fund (EZM) | |||
| USEP | 41.66 | -0.12 | -0.29% |
| Innovator U.S. Equity Ultra Buffer ETF - September (USEP) | |||
| GIEQ | 41.30 | -0.13 | -0.33% |
| Goldman Sachs Data Enhanced International Equity ETF (GIEQ) | |||
| BNDX | 47.47 | -0.17 | -0.36% |
| Vanguard Total International Bond ETF (BNDX) | |||
A.I.dvisor indicates that over the last year, FRST has been closely correlated with BHRB. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if FRST jumps, then BHRB could also see price increases.
| Ticker / NAME | Correlation To FRST | 1D Price Change % | ||
|---|---|---|---|---|
| FRST | 100% | +0.41% | ||
| BHRB - FRST | 69% Closely correlated | -0.11% | ||
| SHBI - FRST | 69% Closely correlated | -0.17% | ||
| BY - FRST | 69% Closely correlated | -0.08% | ||
| HBNC - FRST | 68% Closely correlated | +0.61% | ||
| SMBC - FRST | 68% Closely correlated | -0.60% | ||
More | ||||
| Ticker / NAME | Correlation To FRST | 1D Price Change % |
|---|---|---|
| FRST | 100% | +0.41% |
| FRST (16 stocks) | 77% Closely correlated | -0.18% |
| Regional Banks (356 stocks) | 64% Loosely correlated | +0.13% |
| Banks (429 stocks) | 58% Loosely correlated | +0.24% |
a regional bank
Industry RegionalBanks
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where FRST advanced for three days, in 155 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on FRST as a result. In 44 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 51%.
FRST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Moving Average Convergence Divergence Histogram (MACD) for FRST turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 26 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.
FRST moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FRST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
The Aroon Indicator for FRST entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.828) is normal, around the industry mean (1.262). P/E Ratio (6.704) is within average values for comparable stocks, (13.480). Projected Growth (PEG Ratio) (0.140) is also within normal values, averaging (1.194). Dividend Yield (0.028) settles around the average of (0.035) among similar stocks. P/S Ratio (2.270) is also within normal values, averaging (3.740).
The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating fairly steady price growth. FRST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 78 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FRST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.